BioAge Labs, Inc. (BIOA) — Stock Score Summary

BioAge Labs, Inc. (BIOA) has a MoatMap StockRank of 46/100 based on Quality (36/100), Value (37/100), and Momentum (59/100) factor scores. The current signal is HOLD. BioAge Labs is an early-stage biotech focused on aging therapies; it lacks the revenue, cash flow, and structural moat required for our quality-first investment philosophy.

BioAge Labs is a biotechnology company focused on developing therapeutics to treat age-related diseases and extend healthy human lifespan, using a proprietary platform to identify novel drug targets. Its competitive advantage is a pioneering approach to aging biology, leveraging extensive human data and AI-driven drug discovery to target fundamental aging mechanisms. BioAge is a niche biopharmaceutical company in the emerging field of longevity medicine, with a high-risk, high-reward pipeline.

Key Financial Metrics

Price$15.80
Market Cap$758M
P/E (Forward)-7.89
Price/Book1.99
Return on Equity-26.0%
Return on Invested Capital-29.1%
Debt/Equity1.06
Gross Margin0.0%
Operating Margin-915.4%
Revenue Growth91.0%
Free Cash Flow$-58M

BioAge Labs, Inc. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is BioAge Labs, Inc.’s (BIOA) StockRank?
MoatMap’s StockRank for BioAge Labs, Inc. (BIOA) is 46/100, with a Hold signal. It is a composite of Quality (36), Value (37), and Momentum (59) factor ranks across MoatMap’s 19,000+ stock universe.
Does BioAge Labs, Inc. have an economic moat?
BioAge Labs, Inc. (BIOA) has a Quality factor score of 36/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is BioAge Labs, Inc. a buy, hold, or sell?
MoatMap’s current signal for BioAge Labs, Inc. (BIOA) is Hold, based on a StockRank of 46/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is BioAge Labs, Inc. in?
BioAge Labs, Inc. (BIOA) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (United States).
Browse all ranked stocksBIOA deep dive reportAI ChampionsHow we score stocksSense-check another stock